RARRES2 and cardiovascular disorder: A novel role of chemerin and CMKLR1 in cardiovascular disease is emerging, both as a consequence of this signaling pathway’s known roles in obesity/metabolic syndrome and inflammation (as outlined above) as well as direct actions on the cardiovascular system.